康泰医学：王桂丽持股比例已降至10.00%

Core Viewpoint - Shareholder Wang Guili plans to reduce her stake in Kangtai Medical by a total of 18.9011 million shares, representing 4.70% of the company's total share capital, due to personal funding needs [1] Summary by Sections Shareholder Actions - Wang Guili will reduce her holdings from September 24, 2021, to September 16, 2025, bringing her ownership down to 10.00% after the reduction [1] - The planned reduction includes a maximum of 4 million shares through centralized bidding (1.00% of total share capital) and 8 million shares through block trading (1.99% of total share capital) within three months after the announcement [1] Company Governance - The equity change does not involve a change in the company's controlling shareholder or actual controller, and it will not affect the company's governance structure or ongoing operations [1]